The GDPR (General Data Protection Regulation) includes provisions that support the secondary use of existing health data for scientific research purposes, while also protecting the privacy and data protection rights of individuals.
One of the key ways that the GDPR supports the secondary use of health data for research is through the concept of “legitimate interests”. Article 6(1)(f) of the GDPR allows for the processing of personal data if it is necessary for the legitimate interests of the data controller or a third party, provided that those interests do not override the fundamental rights and freedoms of the data subject. Scientific research can be considered a legitimate interest, provided that appropriate safeguards are in place to protect individuals’ rights and freedoms.
In addition, the GDPR includes provisions that specifically address the use of health data for scientific research. For example, Article 9(2)(j) allows for the processing of special categories of personal data, such as health data, for scientific research purposes, provided that appropriate safeguards are in place.
The GDPR also requires that data controllers implement appropriate technical and organizational measures to ensure the security and confidentiality of personal data, including health data. This includes requirements for data pseudonymization and encryption, as well as procedures for data breach notification.
Overall, the GDPR strikes a balance between protecting individuals’ privacy and data protection rights, and supporting the important public interest in scientific research. By providing a framework for the responsible and transparent use of health data for research purposes, the GDPR can help to facilitate the development of new treatments and interventions that can improve public health outcomes.
Share this story...
Real World Evidence (RWE) 101 – SOPs and Regional Regulations
RWE 101 - SOPs and Regional Regulations In the realm of quality assurance (QA), it's vital that standard operating procedures (SOPs) are crafted in a way that accurately and [...]
Real World Evidence (RWE) 101 – Standard Operating Procedures
RWE 101 - Standard Operating Procedures Standard Operating Procedures (SOPs) are critical for the operation of any business, particularly in regulated industries like pharmaceuticals where precision, safety, and compliance [...]
Real World Evidence (RWE) 101 – Publications
RWE 101 - Publications The term RWE stands for Real-World Evidence, which is evidence derived from real-world data (RWD). RWD are data relating to patient health status and/or the [...]
Real World Evidence (RWE) 101 – Archiving Specifics
RWE 101 - Archiving Specifics Proper archiving of clinical study documents is an important practice for maintaining the quality, integrity, and usability of study data, and for ensuring regulatory [...]
Real World Evidence (RWE) 101 – Archiving Generics
RWE 101 - Archiving Generics In the context of health research, both observational studies and clinical trials are crucial for understanding disease processes, patient outcomes, and the safety and [...]
Real World Evidence (RWE) 101 – Study Close-out
RWE 101 - Study Close-Out Closing out an observational study involves several key steps to ensure that all study activities are concluded properly, and data integrity is maintained. Here [...]







